Advisor
Amgen
Total years of experience :7 years, 9 Months
Study manager for (EPICLIN) study, a Non-Interventional Epidemiological Study for lung cancer.
▪ Study manager for The GERD study, a Non-Interventional Epidemiological Study for GERD.
▪ Establishing a new tool (Questionnaire) for identifying GERD (GERD-Q).
▪ Selected as the contact point between Saudi medical team and both MENA (Middle East North
Africa), and CEEMEA (Central Eastern Europe Middle East Africa) medical teams regarding the
medical information updates, from March 2011 till the end of June 2012.
Oncology and Diabetes) and the (Deputy QPPV) January 2013 - May 2013
▪ Management of 2 MSLs.
Milestones:
-Management of Medical Diabetes alliance team between AstraZeneca, and BMS.
participated in the teasing campaign of Brufen® retard, and in the launch of Brufen® flu, and
Brufen® dispersible
Medical Lead for Oncology and Hematology, responsible for Middle East. June 2017-February 2018
▪ Establishing Shire`s presence in the Middle East region.
▪ Building the base for Shire`s partnership with Key institutions and Medical societies.
▪ Effective Management of the medical interactions with Health and regulatory organizations in 16
countries of the Middle East with different complexities and specifications.
▪ Onboarding the whole Middle East and Euro Asia Middle East Africa teams for oncology and
hematology foundational knowledge.
▪ Responsibilities include communicating disease state and product information to internal and
external customers, performing literature surveillance and analysis, reviewing field-based
promotional and educational materials for scientific accuracy, providing support for key scientific
congresses including creation of Scientific Affairs booths, the development and management of
scientific platforms, scientific advisory boards, and resources for Medical Liaisons, and management
of project-associated budgets.
▪ Planning and delivery of science-based product Medical Communication activities as a component of
Medical/Brand Teams based on local/regional strategies and team priorities.
▪ Review/approval of non-promotional and promotional materials as per SOPs.
▪ Provides conceptual and tool support for advisory boards.
Medical Lead for Ophthalmology and Critical Care lines.
Formulation, Rasayan J. Chem, 11
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).
courses: 2014- 2018. ▪ ESO-ESMO Masterclass in Clinical Oncology. The European School of Oncology. March 2018. 31 (ECMEC®s).